Glucose
- Generic Name
- Glucose
- Brand Names
- Bss Ophthalmic Solution, Citrasate, Clinimix 2.75/5, Clinimix E 2.75/5, Dextroject, Dianeal, H.E.L.P.bicel, Hemosate Ultra, Lactate 1-2-3, Leukotrap, Naturalyte, Nauzene, Normosol-R, Nxstage Pureflow, Olimel, Periolimel, Physioneal 40, Sag-M, Sclerodex, Selectbag One
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- IY9XDZ35W2
- Background
Glucose is a simple sugar (monosaccharide) generated during phosynthesis involving water, carbon and sunlight in plants. It is produced in humans via hepatic gluconeogenesis and breakdown of polymeric glucose forms (glycogenolysis). It circulates in human circulation as blood glucose and acts as an essential energy source for many organisms through aerobic o...
- Indication
Glucose pharmaceutical formulations (oral tablets, injections) are indicated for caloric supply and carbohydrate supplementation in case of nutrient deprivation. It is also used in metabolic disorders such as hypoglycemia.
- Associated Conditions
- Arrhythmia, Caloric Deficit, Edema of the cerebrum, Hypoglycemia, Metabolic Alkalosis
- Associated Therapies
- Blood Specimen Collection, Electrolyte replacement, Nutritional supplementation, Parenteral Nutrition, Parenteral rehydration therapy, Plasmapheresis, Positive cardiac inotropic effect, Total parenteral nutrition therapy, Urine alkalinization therapy, Fluid and electrolyte maintenance therapy
Age-Related Effects of THC
- Conditions
- Interventions
- First Posted Date
- 2020-03-04
- Last Posted Date
- 2023-11-09
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 24
- Registration Number
- NCT04294966
- Locations
- 🇺🇸
University of Chicago Hospital, Chicago, Illinois, United States
🇺🇸University of Chicago, Chicago, Illinois, United States
Pre-emptive Analgesia Effect in Different Psycho-emotional Status Patients During Lower Third Molar Surgical Extractions
- Conditions
- Interventions
- First Posted Date
- 2019-12-17
- Last Posted Date
- 2019-12-17
- Lead Sponsor
- Lithuanian University of Health Sciences
- Target Recruit Count
- 45
- Registration Number
- NCT04202224
- Locations
- 🇱🇹
Lithuanian university of health sciences, Kaunas, Lithuania
Dynamic Connectivity Under Metabolic Constraints
- Conditions
- Interventions
- First Posted Date
- 2019-09-27
- Last Posted Date
- 2019-09-27
- Lead Sponsor
- Stony Brook University
- Target Recruit Count
- 80
- Registration Number
- NCT04106882
- Locations
- 🇺🇸
Bioengineering Building , Stony Brook University, Stony Brook, New York, United States
🇺🇸Martinos Center for Biomedical Research, Building 149, Charlestown, Massachusetts, United States
The Impact of a Preoperative Nerve Block on the Consumption of Sevoflurane in Total Shoulder Arthroplasty
- Conditions
- Interventions
- First Posted Date
- 2019-07-16
- Last Posted Date
- 2024-06-06
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 17
- Registration Number
- NCT04020601
- Locations
- 🇨🇦
University of Alberta Hospital, Edmonton, Alberta, Canada
Individual Differences in Drug Response
- Conditions
- Interventions
- First Posted Date
- 2019-01-18
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 60
- Registration Number
- NCT03809546
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Blood Glucose Response After Oral Intake of Lactulose in Mildly Constipated Patients With Diabetes Mellitus Type 2
- First Posted Date
- 2018-09-12
- Last Posted Date
- 2019-04-12
- Lead Sponsor
- Fresenius Kabi
- Target Recruit Count
- 24
- Registration Number
- NCT03666546
- Locations
- 🇦🇹
Clinical Research Center (CRC), Graz, Austria
CORT125134 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD)
- Conditions
- Interventions
- First Posted Date
- 2018-04-26
- Last Posted Date
- 2019-08-09
- Lead Sponsor
- Corcept Therapeutics
- Target Recruit Count
- 130
- Registration Number
- NCT03508635
- Locations
- 🇬🇧
Quotient Clinical, Nottingham, Nottinghamshire, United Kingdom
A Study to Evaluate a Potassium Normalization Treatment Regimen Including Sodium Zirconium Cyclosilicate (ZS) Among Patients With S-K ≥5.8
- Conditions
- Interventions
- First Posted Date
- 2017-11-09
- Last Posted Date
- 2020-01-28
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 70
- Registration Number
- NCT03337477
- Locations
- 🇷🇺
Research Site, Yekaterinburg, Russian Federation
Exceptional Experiences (EE), Salience & Dopaminergic Neurotransmission
- Conditions
- Interventions
- First Posted Date
- 2017-11-06
- Last Posted Date
- 2017-11-06
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 65
- Registration Number
- NCT03333369
- Locations
- 🇨🇭
Collegium Helveticum, ETH & Universität Zürich, Zürich, Switzerland
First-in-human Study in Healthy Subjects
- Conditions
- Interventions
- Drug: CORT118335, 25 mgDrug: Placebo oral capsuleDrug: CORT118335, 75mgDrug: CORT118335, 225mgDrug: CORT118335, 675mgDrug: CORT118335, 600mgDrug: Prednisone Oral TabletDrug: CORT118335, 375mgDrug: CORT118335, 100mgDrug: Placebo oral suspensionDrug: CORT118335, 300mgDrug: CORT118335, 900mgDrug: CORT118335, 1500mgDrug: CORT118335, 150mgDrug: CORT118335, dose to be determinedDrug: GlucoseDrug: CORT118335, 630mg
- First Posted Date
- 2017-10-20
- Last Posted Date
- 2019-05-24
- Lead Sponsor
- Corcept Therapeutics
- Target Recruit Count
- 143
- Registration Number
- NCT03315338
- Locations
- 🇬🇧
Quotient Clinical, Nottingham, Nottinghamshire, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.